대한내분비학회

메뉴 보기

메뉴 닫기


게시판 검색 ~
번호 카테고리 EnM 인용 제목 저자 저널명 출판년도/월
5034 갑상선 Discovery of Pharmaceutical Composition for Prevention and Treatment in Patient-Derived Metastatic Medullary Thyroid Carcinoma Model. Kim Sang Yong Biomedicines 2022/08
5033 갑상선 Interleukin-4 Receptor Targeting Peptide Decorated Extracellular Vesicles as a Platform for In Vivo Drug Delivery to Thyroid Cancer. Jaetae Lee Biomedicines 2022/08
5032 갑상선 Effect of a Polyglycolic Acid Mesh Sheet (Neoveil Ahn Jong Hyuk Cancers 2022/08
5031 갑상선 Quality of Life of Survivors of Thyroid Cancer Is Not Inferior to That in Subjects without Cancer: Long-Term after Over 5 Years. Kim Min Hee,Dong Jun Lim,Sang Ah Chang Endocrinology and metabolism (Seoul, Korea) 2022/08
5030 갑상선 Efficient Dissociation Protocol for Generation of Single Cell Suspension from Human Thyroid Tissue for Single Cell RNA Sequencing. Lee Seong Eun,Yea Eun Kang Endocrinology and metabolism (Seoul, Korea) 2022/08
5029 갑상선 Thyroid Cancer in Patients with Metabolic Syndrome or Its Components: A Nationwide Population-Based Cohort Study. Park Jae Hyun Cancers 2022/08
5028 갑상선 Is obesity associated with the prognosis of papillary thyroid carcinoma? Jung Min Kim Gland surgery 2022/08
5027 갑상선 Adrenomedullin2 stimulates progression of thyroid cancer in mice and humans under nutrient excess conditions. Sun Wook Cho,Jung Tae Kim,Lee Seong Eun,Yea Eun Kang The Journal of pathology 2022/08

TOP

SNS
instagram facebook twitter
PC버전
대한내분비학회

Copyright ⓒ The Korean Endocrine Society. All rights Reserved

[04146] 서울특별시 마포구 마포대로 109 롯데캐슬프레지던트 101동 2503호
  • 사업자 등록번호 : 106-82-31113
  • 대표자 성명 : 홍은경
  • Tel : 02-714-2428 | Fax : 02-714-5103 | E-mail : endo@endocrinology.or.kr